Literature DB >> 4971651

Cinanserin (SQ. 10,643): a preliminary evaluation in chronic schizophrenic patients.

D M Gallant, M P Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4971651

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  3 in total

1.  Pharmacological studies of cinanserin in human isolated smooth muscle.

Authors:  H L Metcalfe; P Turner
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

2.  Identification and evaluation of coronavirus replicase inhibitors using a replicon cell line.

Authors:  Elke Scandella; Klara K Eriksson; Tobias Hertzig; Christian Drosten; Lili Chen; Chunshan Gui; Xiaomin Luo; Jianhua Shen; Xu Shen; Stuart G Siddell; Burkhard Ludewig; Hualiang Jiang; Stephan Günther; Volker Thiel
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.

Authors:  Lili Chen; Chunshan Gui; Xiaomin Luo; Qingang Yang; Stephan Günther; Elke Scandella; Christian Drosten; Donglu Bai; Xichang He; Burkhard Ludewig; Jing Chen; Haibin Luo; Yiming Yang; Yifu Yang; Jianping Zou; Volker Thiel; Kaixian Chen; Jianhua Shen; Xu Shen; Hualiang Jiang
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.